139 related articles for article (PubMed ID: 14530681)
21. Correlation of human epidermal growth factor receptor protein expression and colorectal cancer.
Yang WJ; Shen XJ; Ma XX; Tan ZG; Song Y; Guo YT; Yuan M
World J Gastroenterol; 2015 Jul; 21(28):8687-96. PubMed ID: 26229411
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of epidermal growth factor receptor expression in cervical carcinoma.
Hale RJ; Buckley CH; Gullick WJ; Fox H; Williams J; Wilcox FL
J Clin Pathol; 1993 Feb; 46(2):149-53. PubMed ID: 8459036
[TBL] [Abstract][Full Text] [Related]
23. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients.
Esteban JM; Felder B; Ahn C; Simpson JF; Battifora H; Shively JE
Cancer; 1994 Sep; 74(5):1575-83. PubMed ID: 7914825
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) expression in relation to cadherin expression in patients with colorectal carcinoma.
Tsujitani S; Saito H; Honboh T; Ataka M; Tanida T; Makino M; Ikeguchi M
Dis Colon Rectum; 2007 Aug; 50(8):1241-9. PubMed ID: 17429708
[TBL] [Abstract][Full Text] [Related]
25. The number of analyzed lymph nodes - a prognostic factor in colorectal cancer.
Edler D; Ohrling K; Hallström M; Karlberg M; Ragnhammar P
Acta Oncol; 2007; 46(7):975-81. PubMed ID: 17917828
[TBL] [Abstract][Full Text] [Related]
26. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
[TBL] [Abstract][Full Text] [Related]
27. Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study.
Madbouly KM; Abbas KS; Hussein AM
Am J Surg; 2014 Jun; 207(6):824-31. PubMed ID: 24112666
[TBL] [Abstract][Full Text] [Related]
28. Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer.
Toi M; Nakamura T; Mukaida H; Wada T; Osaki A; Yamada H; Toge T; Niimoto M; Hattori T
Cancer; 1990 May; 65(9):1980-4. PubMed ID: 2372767
[TBL] [Abstract][Full Text] [Related]
29. Epidermal growth factor receptor levels are lower in carcinomatous than in normal colorectal tissue.
Koenders PG; Peters WH; Wobbes T; Beex LV; Nagengast FM; Benraad TJ
Br J Cancer; 1992 Feb; 65(2):189-92. PubMed ID: 1739615
[TBL] [Abstract][Full Text] [Related]
30. Lymph Node Micrometastasis Cannot Be Considered as Positive Lymph Node in Nonmetastatic Colorectal Cancer.
Hong KD; Um JW; Min BW; Ji WB; Choi JW; Kim YS
Am Surg; 2017 Feb; 83(2):127-133. PubMed ID: 28228198
[TBL] [Abstract][Full Text] [Related]
31. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.
De Jong KP; Stellema R; Karrenbeld A; Koudstaal J; Gouw AS; Sluiter WJ; Peeters PM; Slooff MJ; De Vries EG
Hepatology; 1998 Oct; 28(4):971-9. PubMed ID: 9755233
[TBL] [Abstract][Full Text] [Related]
32. Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience.
Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
Jpn J Clin Oncol; 2000 Jan; 30(1):12-6. PubMed ID: 10770562
[TBL] [Abstract][Full Text] [Related]
33. Number and size of lymph nodes recovered from dukes B rectal cancers: correlation with prognosis and histologic antitumor immune response.
Murphy J; Pocard M; Jass JR; O'Sullivan GC; Lee G; Talbot IC
Dis Colon Rectum; 2007 Oct; 50(10):1526-34. PubMed ID: 17828403
[TBL] [Abstract][Full Text] [Related]
34. C-erbB-2 oncoprotein content in colorectal cancer and in surrounding mucosa: relationship with clinicopathologic parameters and prognostic significance.
Vizoso F; Villar C; Rodríguez JC; Raigoso P; García-Muñiz JL; Allende MT; García-Moran M
Int J Surg Investig; 2000; 1(6):483-93. PubMed ID: 11729856
[TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial growth factor receptors 1,3 and caveolin-1 are implicated in colorectal cancer aggressiveness and prognosis--correlations with epidermal growth factor receptor, CD44v6, focal adhesion kinase, and c-Met.
Garouniatis A; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
Tumour Biol; 2013 Aug; 34(4):2109-17. PubMed ID: 23580180
[TBL] [Abstract][Full Text] [Related]
36. Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases.
Karamitopoulou E; Zlobec I; Koumarianou A; Patsouris ES; Peros G; Lugli A
Cancer; 2010 Oct; 116(19):4474-86. PubMed ID: 20572035
[TBL] [Abstract][Full Text] [Related]
37. Oncoproteins and tumor progression in papillary thyroid carcinoma: presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21-ras protein, and proliferation indicators in relation to tumor recurrences and patient survival.
Akslen LA; Varhaug JE
Cancer; 1995 Nov; 76(9):1643-54. PubMed ID: 8635070
[TBL] [Abstract][Full Text] [Related]
38. Association of epidermal growth factor-related peptides and type I receptor tyrosine kinase receptors with prognosis of human colorectal carcinomas.
Saeki T; Salomon DS; Johnson GR; Gullick WJ; Mandai K; Yamagami K; Moriwaki S; Tanada M; Takashima S; Tahara E
Jpn J Clin Oncol; 1995 Dec; 25(6):240-9. PubMed ID: 8523820
[TBL] [Abstract][Full Text] [Related]
39. Increased epidermal growth factor receptors in gastric carcinomas.
Pfeiffer A; Rothbauer E; Wiebecke B; Pratschke E; Krämling HJ; Mann K
Gastroenterology; 1990 Apr; 98(4):961-7. PubMed ID: 2311877
[TBL] [Abstract][Full Text] [Related]
40. Increased epidermal growth factor receptor expression at the invasive margin is a negative prognostic factor in colorectal cancer.
Ljuslinder I; Melin B; Henriksson ML; Öberg Å; Palmqvist R
Int J Cancer; 2011 May; 128(9):2031-7. PubMed ID: 20635387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
